Medical Marijuana Inc.'s HempMedsPX to Exhibit at International Esthetics,
Cosmetics & Spa Conference
HempMedsPX Will Exhibit Cannabidiol (CBD)-Rich Hemp Oil Products at Premier
Spa and Wellness Event in Ft. Lauderdale, Fla.
SAN DIEGO, Sept. 20, 2013 (GLOBE NEWSWIRE) -- Medical Marijuana Inc. (OTC
Pink:MJNA) is pleased to announce to shareholders and the general public that
HempMedsPX—a corporate portfolio company of Medical Marijuana Inc. and the
exclusive master distributor and contracted marketing company for CannaVest
Corp. (OTC:CANV) and Medical Marijuana Inc.—will be exhibiting Cibaderm,
Cibdex and CanChew gum at the International Esthetics, Cosmetics & Spa
Conference (IECSC) in Ft. Lauderdale, Florida from September 22-23, 2013.
"IECSC is the first exposure the spa industry will have to our unique CBD-rich
hemp oil personal care and wellness supplements," said Charles Vest, Director
of Communications for HempMedsPX. "We are excited to have some of the top spa
and wellness companies and buyers get to know us and the benefits of
hemp-based CBD product lines for their businesses."
Presented by American Spa, IECSC is expected to draw over 5,500 industry
attendees from over two dozen countries, representing hundreds of spa and
wellness companies. Now in its fifteenth year, IECSC is one of the most
respected business and educational conferences for industry professionals to
learn about the latest spa and wellness trends, techniques, and new spa
For more information about IECSC Florida, please visit their website:
IECSC.com. For more information on the products being exhibited, please visit
HempMedsPX.com or call 866-273-8502.
HempMedsPX offers mainstream marketing, sales, customer service, and logistics
for the cannabis industry. HempMedsPX is a corporate portfolio company of
Medical Marijuana Inc. (OTC:MJNA) and the exclusive master distributor and
contracted marketing company for CannaVest Corp. (OTC:CANV) and Medical
Marijuana Inc. In addition to handling sales and distribution of hemp
cannabidiol (CBD) products, HempMedsPX is the communication hub for the
Medical Marijuana Inc. family of companies.
About CanChew Biotechnologies
CanChew Biotechnologies focuses on the treatment of pain and other medical
disorders with the application of chewing gum-based cannabis/cannabinoid
medical products as well as food and nutraceutical products for general
The company is focused on the R&D and execution of their clinical development
plan and potential out-licensing of their technology. Clinical development
focuses on the R&D of the formulation, production and the development of
chewing gum-based products for the treatment of conditions like pain, nausea
and vomiting, anorexia, spasticity and various other medical issues. For more
information on the company, visit CanChewBiotech.com.
About Cannagum Marketing Group
Cannagum Marketing Group, a wholly-owned subsidiary of CanChew
Biotechnologies, was incorporated to sell, market, and distribute CanChew gum.
The company was formed to comply with federal regulations that require the
company to clearly distinguish CanChew gum, a food product sold without
claims, from MedChewRX, a pharmaceutical product that is in development by
CanChew Biotechnologies. For more information, please visit
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators,
leveraging our team of professionals to source, evaluate and purchase
value-added companies and products, while allowing them to keep their
integrity and entrepreneurial spirit. We strive to create awareness within our
industry, develop environmentally friendly, economically sustainable
businesses, while increasing shareholder value. For more information, please
visit the company's website at: www.MedicalMarijuanaInc.com
About CannaVest Corp.
CannaVest Corp. (OTC:CANV) is in the business of investing and developing
hemp-based cannabinoid companies. CannaVest Corp. also develops, produces,
markets and sells end-consumer products to the nutraceutical industry
containing the hemp plant extract, cannabidiol (CBD). Additionally, the
company resells—to third parties—raw product acquired by CannaVest Corp.
pursuant to the company's supply relationships in Europe. CannaVest Corp.
seeks to take advantage of an emerging worldwide trend to re-energize the
production of industrial hemp and to foster its many uses for consumers.
Cannabinoids (cannabidiol/CBD) are natural constituents of the hemp plant and
CBD is derived from hemp stalk and seed. Additional information is available
from OTCMarkets.com or by visiting CannaVest.com.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to
diagnose, treat or cure any disease.
This press release may contain certain forward-looking statements and
information, as defined within the meaning of Section 27A of the Securities
Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is
subject to the Safe Harbor created by those sections. This material contains
statements about expected future events and/or financial results that are
forward-looking in nature and subject to risks and uncertainties. Such
forward-looking statements by definition involve risks, uncertainties and
other factors, which may cause the actual results, performance or achievements
of Medical Marijuana, Inc. and CannaVest Corp. to be materially different from
the statements made herein.
Medical Marijuana, Inc., CannaVest Corp., and HempMedsPX do not sell or
distribute any products that are in violation of the United States Controlled
Substances Act (US.CSA). These companies do grow, sell and distribute
hemp-based products and are involved with Federally Legal Distribution of
Medical Marijuana based products within certain international markets.
CONTACT: Investor relations contact:
Stuart T. Smith
Medical Marijuana, Inc.
Toll Free: 888-OTC-MJNA (888-682-6562)
Press spacebar to pause and continue. Press esc to stop.